Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Effects of a Ketogenic Diet on [18F]FDG-PET Imaging in a Mouse Model of Lung Cancer.

Cussó L, Musteanu M, Mulero F, Barbacid M, Desco M.

Mol Imaging Biol. 2018 Jul 2. doi: 10.1007/s11307-018-1233-8. [Epub ahead of print]

PMID:
29968182
2.

Afatinib restrains K-RAS-driven lung tumorigenesis.

Moll HP, Pranz K, Musteanu M, Grabner B, Hruschka N, Mohrherr J, Aigner P, Stiedl P, Brcic L, Laszlo V, Schramek D, Moriggl R, Eferl R, Moldvay J, Dezso K, Lopez-Casas PP, Stoiber D, Hidalgo M, Penninger J, Sibilia M, Győrffy B, Barbacid M, Dome B, Popper H, Casanova E.

Sci Transl Med. 2018 Jun 20;10(446). pii: eaao2301. doi: 10.1126/scitranslmed.aao2301.

PMID:
29925635
3.

c-RAF Ablation Induces Regression of Advanced Kras/Trp53 Mutant Lung Adenocarcinomas by a Mechanism Independent of MAPK Signaling.

Sanclemente M, Francoz S, Esteban-Burgos L, Bousquet-Mur E, Djurec M, Lopez-Casas PP, Hidalgo M, Guerra C, Drosten M, Musteanu M, Barbacid M.

Cancer Cell. 2018 Feb 12;33(2):217-228.e4. doi: 10.1016/j.ccell.2017.12.014. Epub 2018 Jan 27.

PMID:
29395869
4.

Whole Exome Sequencing of Rapid Autopsy Tumors and Xenograft Models Reveals Possible Driver Mutations Underlying Tumor Progression.

Xie T, Musteanu M, Lopez-Casas PP, Shields DJ, Olson P, Rejto PA, Hidalgo M.

PLoS One. 2015 Nov 10;10(11):e0142631. doi: 10.1371/journal.pone.0142631. eCollection 2015.

5.

SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial.

Hidalgo M, Plaza C, Musteanu M, Illei P, Brachmann CB, Heise C, Pierce D, Lopez-Casas PP, Menendez C, Tabernero J, Romano A, Wei X, Lopez-Rios F, Von Hoff DD.

Clin Cancer Res. 2015 Nov 1;21(21):4811-8. doi: 10.1158/1078-0432.CCR-14-3222. Epub 2015 Jul 13. Erratum in: Clin Cancer Res. 2016 Dec 15;22(24):6302.

6.

Myeloid STAT3 promotes formation of colitis-associated colorectal cancer in mice.

Pathria P, Gotthardt D, Prchal-Murphy M, Putz EM, Holcmann M, Schlederer M, Grabner B, Crncec I, Svinka J, Musteanu M, Hoffmann T, Filipits M, Berger W, Poli V, Kenner L, Bilban M, Casanova E, Müller M, Strobl B, Bayer E, Mohr T, Sexl V, Eferl R.

Oncoimmunology. 2015 Jan 22;4(4):e998529. eCollection 2015 Apr.

7.

Metabolomic evaluation of Mitomycin C and rapamycin in a personalized treatment of pancreatic cancer.

Navarrete A, Armitage EG, Musteanu M, García A, Mastrangelo A, Bujak R, López-Casas PP, Hidalgo M, Barbas C.

Pharmacol Res Perspect. 2014 Dec;2(6):e00067. doi: 10.1002/prp2.67. Epub 2014 Aug 24.

8.

STAT3β controls inflammatory responses and early tumor onset in skin and colon experimental cancer models.

Marino F, Orecchia V, Regis G, Musteanu M, Tassone B, Jon C, Forni M, Calautti E, Chiarle R, Eferl R, Poli V.

Am J Cancer Res. 2014 Sep 6;4(5):484-94. eCollection 2014.

9.

Reply: 'Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer'.

Alvarez R, Musteanu M, Garcia-Garcia E, Lopez-Casas PP, Megias D, Guerra C, Muñoz M, Quijano Y, Cubillo A, Rodriguez-Pascual J, Plaza C, de Vicente E, Prados S, Tabernero S, Barbacid M, Lopez-Rios F, Hidalgo M.

Br J Cancer. 2014 Oct 14;111(8):1677-8. doi: 10.1038/bjc.2014.129. Epub 2014 Mar 18. No abstract available.

10.

Stromal disrupting effects of nab-paclitaxel in pancreatic cancer.

Alvarez R, Musteanu M, Garcia-Garcia E, Lopez-Casas PP, Megias D, Guerra C, Muñoz M, Quijano Y, Cubillo A, Rodriguez-Pascual J, Plaza C, de Vicente E, Prados S, Tabernero S, Barbacid M, Lopez-Rios F, Hidalgo M.

Br J Cancer. 2013 Aug 20;109(4):926-33. doi: 10.1038/bjc.2013.415. Epub 2013 Aug 1.

11.

A mouse model to identify cooperating signaling pathways in cancer.

Musteanu M, Blaas L, Zenz R, Svinka J, Hoffmann T, Grabner B, Schramek D, Kantner HP, Müller M, Kolbe T, Rülicke T, Moriggl R, Kenner L, Stoiber D, Penninger JM, Popper H, Casanova E, Eferl R.

Nat Methods. 2012 Sep;9(9):897-900. doi: 10.1038/nmeth.2130. Epub 2012 Aug 5.

PMID:
22863881
12.

The use of bacterial artificial chromosomes for recombinant protein production in mammalian cell lines.

Blaas L, Musteanu M, Grabner B, Eferl R, Bauer A, Casanova E.

Methods Mol Biol. 2012;824:581-93. doi: 10.1007/978-1-61779-433-9_31.

PMID:
22160921
13.

A mouse tool for conditional mutagenesis in ovarian granulosa cells.

Grabner B, Blaas L, Musteanu M, Hoffmann T, Birbach A, Eferl R, Casanova E.

Genesis. 2010 Oct 1;48(10):612-7. doi: 10.1002/dvg.20664.

PMID:
20715176
14.

Signal transducer and activator of transcription 3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitis.

Mair M, Zollner G, Schneller D, Musteanu M, Fickert P, Gumhold J, Schuster C, Fuchsbichler A, Bilban M, Tauber S, Esterbauer H, Kenner L, Poli V, Blaas L, Kornfeld JW, Casanova E, Mikulits W, Trauner M, Eferl R.

Gastroenterology. 2010 Jun;138(7):2499-508. doi: 10.1053/j.gastro.2010.02.049. Epub 2010 Feb 26.

PMID:
20193684
15.

Disruption of the growth hormone--signal transducer and activator of transcription 5--insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasis.

Blaas L, Kornfeld JW, Schramek D, Musteanu M, Zollner G, Gumhold J, van Zijl F, Schneller D, Esterbauer H, Egger G, Mair M, Kenner L, Mikulits W, Eferl R, Moriggl R, Penninger J, Trauner M, Casanova E.

Hepatology. 2010 Apr;51(4):1319-26. doi: 10.1002/hep.23469.

16.

Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice.

Musteanu M, Blaas L, Mair M, Schlederer M, Bilban M, Tauber S, Esterbauer H, Mueller M, Casanova E, Kenner L, Poli V, Eferl R.

Gastroenterology. 2010 Mar;138(3):1003-11.e1-5. doi: 10.1053/j.gastro.2009.11.049. Epub 2009 Dec 4.

PMID:
19962983
17.

Bacterial artificial chromosomes improve recombinant protein production in mammalian cells.

Blaas L, Musteanu M, Eferl R, Bauer A, Casanova E.

BMC Biotechnol. 2009 Jan 14;9:3. doi: 10.1186/1472-6750-9-3.

18.

PhiC31-mediated cassette exchange into a bacterial artificial chromosome.

Blaas L, Musteanu M, Zenz R, Eferl R, Casanova E.

Biotechniques. 2007 Nov;43(5):659-60, 662, 664.

19.

Regulation of the expression of the oncogene EVI1 through the use of alternative mRNA 5'-ends.

Aytekin M, Vinatzer U, Musteanu M, Raynaud S, Wieser R.

Gene. 2005 Aug 15;356:160-8.

PMID:
16014322

Supplemental Content

Loading ...
Support Center